наблюдавани различия между прилаганата средна седмична доза при интравенозно или подкожно инжектиране. ко
who were either receiving or not receiving dialysis determined pharmacokinetic profiles for sampling periods up to 1 week (168 hours) after a single subcutaneous or intravenous dose.